WuXi PharmaTech (603259): Interim Report Performance Exceeds Expectation Leader Value Continues to Reflect

WuXi PharmaTech (603259): Interim Report Performance Exceeds Expectation Leader Value Continues to Reflect Report Summary: Events: On August 19, 2019, the company released its 2019 Interim Report and achieved operating income of 58.90,000 yuan, an increase of 33 in ten years.7%, net profit attributable to mother 10.600 million, a decrease of 16 a year.9%, net…

Haier Bio (688139): From the leader of biomedical cryogenic storage to the leader of IoT solutions

Haier Bio (688139): From the leader of biomedical cryogenic storage to the leader of IoT solutions Investment points from biomedical low-temperature storage leader to IoT solution leader: R & D, production, and sales of major military biomedical low-temperature storage devices are advanced scientific research and innovation capabilities in the field of low-temperature storage, and have…

Weihai Guangtai (002111) Company Dynamics Review: Three Major Business Units Bloom in Third Quarter Results Exceed Expectations

Weihai Guangtai (002111) Company Dynamics Review: Three Major Business Units Bloom in Third Quarter Results Exceed Expectations Core point of view events: On August 30, 2019, the company released its 2019 semi-annual report. From January to June 2019, the company achieved revenue 9. 6.6 billion, a decline of 3 per year. 19%, achieving net profit…

Yangnong Chemical (600486) 2019H1 Review: Performance Growth Meets Expectations Ranking Ranks One Billion Profit Grade Echelon Optimistic for Gold for Four Years

Yangnong Chemical (600486) 2019H1 Review: Performance Growth Meets Expectations Ranking Ranks One Billion Profit Grade Echelon Optimistic for Gold for Four Years The company released its semi-annual report for 2019, reporting that the combined company realized revenue28. 9.4 billion (YoY-6. 49%), net profit attributable to mother 6. . 2.7 billion (+11. 46%); of which the…

Jinhe Industry (002597) 2018 Annual Report and 2019 First Quarterly Report Advance Commentary: Cost Advantages Build Barriers Optimistic for Long-term Performance Growth

Jinhe Industry (002597) 2018 Annual Report and 2019 First Quarterly Report Advance Commentary: Cost Advantages Build Barriers Optimistic for Long-term Performance Growth Due to the decline in the prices of several products, the company’s net profit attributable to its mother for -18 years is -10 per year.8% is expected to return to mother’s net profit…

Rongsheng Development (002146): Performance Innovation Released, Land Acquisition Expected to Return to Expansion

Rongsheng Development (002146): Performance Innovation Released, Land Acquisition Expected to Return to Expansion Investment Highlights: Event: The company released its 2018 annual report, which achieved operating income of USD 56.4 billion in 2018, an annual growth of 45.6%, achieving net profit attributable to shareholders of the parent company.60,000 yuan, an increase of 31 in ten…